Defining left atrial (LA) function has recently emerged as a powerful parameter, particularly
in evaluation of left ventricular (LV) diastolic dysfunction (LVDD) and heart failure with …

Highlights•The LA is emerging as a biomarker for evaluation of diastolic dysfunction, AF, and
HFpEF.•LA size, although routinely evaluated by 2DE, may be more accurately evaluated by …

The understanding of atrial fibrillation (AF) evolved from a sole rhythm disturbance towards
the complex concept of a cardiomyopathy based on arrhythmia substrates. There is …

The left atrium is considered a biomarker for adverse cardiovascular outcomes, particularly
in patients with left ventricular diastolic dysfunction and atrial fibrillation in whom left atrial …

This review discusses the evolving topic of atrial cardiomyopathy concerning valvular heart
disease. The pathogenesis of atrial cardiomyopathy involves multiple factors, such as …

The aim of this study was to determine whether left atrial ejection fraction (LAEF) quantified
with cardiovascular magnetic resonance (CMR) was different between heart failure with …

Abstract Objectives Cardiac involvement in Anderson-Fabry disease (AFD) results in
myocardial lipid depositions. An early diagnosis can maximize therapeutic benefit. Thus, this …

Background A significant number of patients experience recurrent atrial fibrillation (AF) after
ablation. Various risk scores have been described that may predict outcomes after AF …

The 2020 ESC atrial fibrillation (AF) guidelines suggest the novel 4S-AF scheme for the
characterization of AF. Imaging techniques could be helpful for this objective in everyday …

Background Prognostic significance of left atrial (LA) function in patients with atrial fibrillation
(AF) is poorly defined. Objective To examine the association of LA function measured with …